Alterity Therapeutics to Present at the 46 th Annual Canaccord Genuity Growth Conference MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – 6 August 2026: Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...
Alterity to Present at Canaccord Genuity Growth Conference
Filed with ASX · · 3 pages · English
Release
Alterity Therapeutics Ltd. on 6ix
Story so far
Earlier from Alterity Therapeutics
- Application for quotation of securities - ATH
- Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update
- Quarterly Activities/Appendix 4C Cash Flow Report
- Upcoming Expiry of ATHO Listed Options
- Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026
Later from Alterity Therapeutics
- Granted New U.S. Composition of Matter Patent for ATH434
- Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434
- Disclosure Under Takeovers Panel GN 20
- Appendix 4G
- Corporate Governance Statement
Follow Alterity Therapeutics into a list and get an email when it puts out news.
Follow Alterity Therapeutics